| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
First Department of Internal Medicine, Nagoya University School of Medicine, 65, Tsurumai-cho, Showa-ku, Nagoya, Japan
The effect of L-asparaginase on immunosuppression in mice was studied with procedures measuring the ability to produce circulating antibodies against sheep erythrocytes and allogeneic tumor cells and the incidence of tumor take in the allogeneic mice. The production of anti-sheep erythocyte antibodies on primary immune response in C57BL/Na x A/Jax F1 mice was markedly suppressed at a dose of 25 i.u. of L-asparaginase/mouse, and the degree of the immunosupression was just parallel to the dose of enzyme administered. On the contrary, the enzyme failed to suppress the secondary immune response to sheep erythrocytes. The production of cytotoxic antibody in mice bearing allogeneic tumors was also depressed by the enzyme treatment; however, the duration of the immunosuppression was temporary. Successful tumor allograft was observed with enzyme treatment in the systems of C57BL/Na versus L1210 and CBA/Na versus EL4. The minimum effective dose for allogeneic tumor take was 1000 i.u. of L-asparaginase/mouse for a system of C57BL/Na versus L1210 and 200 i.u. for a system of CBA/Na versus EL4. Tumor allograft in a system of C57BL/Na versus 6C3HED-OG or -RG was regressed at a dose of 800 to 1000 i.u. of L-asparaginase. Histological findings revealed that the cells associated with immune reactions were scarce in the tumor-grafted area and ascites of the enzyme-treated mice, as compared to those of the 0.9% NaCl solution-treated mice. These results indicate that L-asparaginase acts as one of the potent immunosuppressive agents. The mechanisms of immunosuppression by the enzyme are discussed.
Received 7/23/69. Accepted 9/25/70.
This article has been cited by other articles:
![]() |
H. Friedman L-Asparaginase Induced Immunosuppression: Inhibition of Bone Marrow Derived Antibody Precursor Cells Science, October 8, 1971; 174(4005): 139 - 141. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |